📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Omthera

1.1 - Company Overview

Omthera Logo

Omthera

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of specialty pharmaceutical therapies in clinical development for dyslipidemia and elevated triglyceride levels, serving patients at increased risk of cardiovascular disease.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Omthera

Altimmune Logo

Altimmune

HQ: United States Website
  • Description: Provider of vaccines and other biological products to address unmet market and public health needs, using proprietary non-invasive intranasal delivery to stimulate robust and durable immune responses for prevention; programs include pemvidutide, a GLP-1/glucagon dual receptor agonist being developed for obesity and for metabolic dysfunction-associated steatohepatitis (MASH). Proof of principle shown in animals and initial human clinical studies.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Altimmune company profile →
Ysopia Bioscience Logo

Ysopia Bioscience

HQ: France Website
  • Description: Provider of cutting-edge microbiome-based biotherapies in clinical-stage development.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Ysopia Bioscience company profile →
Corline Biomedical Logo

Corline Biomedical

HQ: Sweden Website
  • Description: Provider of heparin-based solutions to improve kidney transplantation, cell therapies and regenerative medicine. Offers Renaparin to enhance kidney transplant outcomes and Cytoparin for cell therapies and treatment of type 1 diabetes, using proprietary heparin technology.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Corline Biomedical company profile →
Viking Therapeutics Logo

Viking Therapeutics

HQ: United States Website
  • Description: Provider of novel therapeutics in development targeting metabolic and endocrine disorders, including oral TRβ agonists (VK2809 for lipid/metabolic disorders incl. NASH; VK0214 for X-ALD), a dual GLP-1/GIP agonist (VK2735) for obesity, an oral FBPase inhibitor (VK0612) for type 2 diabetes, a DGAT-1 inhibitor (VK1430) for hypertriglyceridemia/NASH, and an oral non-steroidal SARM (VK5211) for recovery after non-elective hip fracture surgery.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Viking Therapeutics company profile →
Zystor Logo

Zystor

HQ: United States Website
  • Description: Provider of enzyme replacement therapies under development for the treatment of lysosomal storage diseases; privately held biotechnology company.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Zystor company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Omthera

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Omthera

2.2 - Growth funds investing in similar companies to Omthera

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Omthera

4.2 - Public trading comparable groups for Omthera

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Omthera

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Omthera

What does Omthera do?

Omthera is a provider of specialty pharmaceutical therapies in clinical development for dyslipidemia and elevated triglyceride levels, serving patients at increased risk of cardiovascular disease.

Who are Omthera's competitors?

Omthera's competitors and similar companies include Altimmune, Ysopia Bioscience, Corline Biomedical, Viking Therapeutics, and Zystor.

Where is Omthera headquartered?

Omthera is headquartered in United States.

How many employees does Omthera have?

Omthera has 1,000 employees 🔒.

When was Omthera founded?

Omthera was founded in 2010 🔒.

What sector and industry vertical is Omthera in?

Omthera is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Omthera

Who are the top strategic acquirers in Omthera's sector and industry

Top strategic M&A buyers and acquirers in Omthera's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Omthera?

Top strategic M&A buyers groups and sectors for Omthera include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Omthera's sector and industry vertical

Which are the top PE firms investing in Omthera's sector and industry vertical?

Top PE firms investing in Omthera's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Omthera's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Omthera's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Omthera's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Omthera include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Omthera's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Omthera?

The key public trading comparables and valuation benchmarks for Omthera include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Omthera for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Omthera with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Omthera's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Omthera with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Omthera's' sector and industry vertical?

Access recent funding rounds and capital raises in Omthera's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Omthera